| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $76K | +65.6% |
| Cost of Revenue | $69K | -18.6% |
| Gross Profit | $7K | +117.5% |
| R&D Expense | $1.0M | +16.3% |
| SG&A Expense | $4.1M | +14.3% |
| Operating Income | -$7.1M | -27.9% |
| Pre-tax Income | -$7.2M | -3.4% |
| Income Tax | $0 | — |
| Net Income | -$7.2M | -3.4% |
| EPS (Basic) | -$13.61 | +99.8% |
| EPS (Diluted) | -$13.61 | +99.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.0M | +2548.6% |
| Accounts Receivable | $30K | +62.0% |
| Current Assets | $12.4M | +1403.9% |
| Total Assets | $13.7M | +543.9% |
| Current Liabilities | $837K | -27.4% |
| Total Liabilities | $837K | -27.4% |
| Stockholders' Equity | $12.8M | +1223.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.2M | -35.9% |
| Capital Expenditures | $22K | +320.9% |
| Investing Cash Flow | -$204K | +36.7% |
| Financing Cash Flow | $18.9M | +276.9% |
| Free Cash Flow | -$7.2M | -36.2% |